SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-20-275595
Filing Date
2020-10-23
Accepted
2020-10-23 17:17:01
Documents
18
Period of Report
2020-10-23

Document Format Files

Seq Description Document Type Size
1 PRE 14A d36630dpre14a.htm PRE 14A 1129436
2 GRAPHIC g366301n.jpg GRAPHIC 8505
3 GRAPHIC g366302.jpg GRAPHIC 7653
4 GRAPHIC g36630g01v55.jpg GRAPHIC 34767
5 GRAPHIC g36630g03w61.jpg GRAPHIC 88408
6 GRAPHIC g36630g05k18.jpg GRAPHIC 46074
7 GRAPHIC g36630g06i46.jpg GRAPHIC 114142
8 GRAPHIC g36630g07d68.jpg GRAPHIC 55469
9 GRAPHIC g36630g08u52.jpg GRAPHIC 62082
10 GRAPHIC g36630g12k00.jpg GRAPHIC 45641
11 GRAPHIC g36630g15k32.jpg GRAPHIC 50222
12 GRAPHIC g36630g16m01.jpg GRAPHIC 32404
13 GRAPHIC g36630g48y58.jpg GRAPHIC 26000
14 GRAPHIC g36630g52t54.jpg GRAPHIC 18454
15 GRAPHIC g36630g78j78.jpg GRAPHIC 55742
16 GRAPHIC g36630img03.jpg GRAPHIC 1674
17 GRAPHIC g36630img04.jpg GRAPHIC 1787
18 GRAPHIC g36630img05.jpg GRAPHIC 1838
  Complete submission text file 0001193125-20-275595.txt   1984224
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36620 | Film No.: 201258497
SIC: 2834 Pharmaceutical Preparations